| __timestamp | BioMarin Pharmaceutical Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 302156000 | 4042025 |
| Thursday, January 1, 2015 | 402271000 | 5279557 |
| Friday, January 1, 2016 | 476593000 | 8073913 |
| Sunday, January 1, 2017 | 554336000 | 44864073 |
| Monday, January 1, 2018 | 604353000 | 53488904 |
| Tuesday, January 1, 2019 | 680924000 | 65896361 |
| Wednesday, January 1, 2020 | 737669000 | 69968267 |
| Friday, January 1, 2021 | 759375000 | 92047281 |
| Saturday, January 1, 2022 | 854009000 | 131819000 |
| Sunday, January 1, 2023 | 937300000 | 87501000 |
| Monday, January 1, 2024 | 1009025000 |
Unveiling the hidden dimensions of data
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. BioMarin Pharmaceutical Inc. and Pharming Group N.V. have taken different paths in this regard over the past decade. From 2014 to 2023, BioMarin's SG&A expenses have surged by over 200%, reflecting its aggressive expansion strategy. In contrast, Pharming Group N.V. has maintained a more conservative approach, with a modest increase of around 2,000% in the same period, albeit from a much smaller base. This stark difference highlights BioMarin's focus on scaling operations, while Pharming emphasizes cost control. As the industry evolves, these strategies will play a pivotal role in shaping their financial health and market positioning.
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and BioMarin Pharmaceutical Inc.
Comparing SG&A Expenses: Insmed Incorporated vs BioMarin Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Bio-Techne Corporation and Pharming Group N.V.
Cost Management Insights: SG&A Expenses for BioMarin Pharmaceutical Inc. and Ascendis Pharma A/S
Who Optimizes SG&A Costs Better? BioMarin Pharmaceutical Inc. or Madrigal Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc. or Pharming Group N.V.: Who Invests More in Innovation?
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Vericel Corporation Trends and Insights
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Xencor, Inc. Trends and Insights
Comparing SG&A Expenses: Pharming Group N.V. vs TG Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Pharming Group N.V. vs Lantheus Holdings, Inc.
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Xencor, Inc.